跳至主要内容
临床试验/NCT03412929
NCT03412929终止不适用

A Clinical Evaluation of a Manuka-Honey Impregnated Dressing at Removing Necrotic Tissue From Chronic Foot and Ankle Wounds

Medline Industries2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2018年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
8
试验地点
2
主要终点
Change in Necrotic Tissue

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of a honey-impregnated wound dressing at removing necrotic tissue in subjects with chronic foot or ankle wounds.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female at least 18 years of age
  • Subject has a qualified chronic foot or ankle wound, sized 1cm2 to 25 cm2 for ≥ 4 weeks in duration
  • Must have necrotic tissue at least 25% of wound area
  • The wound type matches one of the indicated wounds listed on the product labeling:
  • Leg ulcers
  • Pressure ulcers
  • Diabetic foot ulcers
  • First and second degree burns
  • Surgical wounds
  • Trauma wounds
  • Subject has adequate circulation as demonstrated by biphasic or triphasic Doppler waveform, consistent with adequate blood flow, within 3 months prior to study enrollment. If monophasic on exam, the non-invasive tests must display Ankle Brachial Index over 0.8 and no worse than mild disease on segmental pressures.
  • Subject is likely to be compliant with instructions for case, such as following institutional standard of care directions, offloading, and keeping the wound area protected from environmental contaminants
  • Type I/II diabetic subjects that meet the following criteria:
  • Random blood glucose is less than 450 mg/dL within 30 days of the screening visit

排除标准

  • Subject has a known sensitivity or allergy to honey based products, bee venom, or other ingredients in product
  • The subject is breastfeeding, pregnant, or has intentions of becoming pregnant during the course of their study participation
  • Wound duration ≥ 52 weeks
  • The subject has a prognosis that indicated unlikely survival past the study period
  • The subject is currently receiving dialysis
  • Gangrene is present in the target wound
  • Patient's wound is infected
  • The subject's diagnosis indicates third degree burns
  • The subject has received any treatment prior to study enrollment that may, in the opinion of an Investigator, affect the outcome of the study
  • In the opinion of an Investigator, the subject is otherwise not suitable for study participation, such as the subject is likely to be non-compliant with study requirements

结局指标

主要结局

Change in Necrotic Tissue

时间窗: From initial date of application to weekly visits assessed up to 4 weeks.

The percent change in necrotic tissue will serve as the primary endpoint.

次要结局

  • Bates-Jensen Wound Assessment Tool Score(The BWAT score will be recorded at weekly visits over fours weeks for each subject.)
  • Odor(The odor score will be recorded at weekly visits over four weeks for each subject.)
  • Wound Closure(From initial date of application to weekly visits assessed up to 4 weeks.)
  • Infections(From initial date of application to weekly visits assessed up to 4 weeks.)
  • Pain Score(The pain score will be recorded at weekly visits over four weeks for each subject.)

研究者

发起方
Medline Industries
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验